Advancing drug development by leveraging microdissection for proteogenomic analysis of histological sections. Pathological evaluation of tumor immune microenvironment before first-line anti-PD1 plus ...
This study was approved by the Medical Ethics Committee of Qingdao Municipal Hospital (approval No. 2024-KY-035) and was conducted according to the guidelines of the Declaration of Helsinki. Written ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results